Interactions between oligodendrocytes and microglia: A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing

Brain

Volumn 115, Issue 6, 1992, Pages 1611-1631

  Zajicek, J P ^a   Wing, M ^b   Scolding, N J ^a   Compston, D A S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COMPLEMENT; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; MYELIN; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL ADHESION; CELL CONTACT; CELL CULTURE; CELL INTERACTION; CELL KILLING; CELL SECRETION; CYTOTOXICITY; MACROPHAGE; MICROGLIA; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; T LYMPHOCYTE;

ANIMAL; CELL ADHESION; CELL COMMUNICATION; COMPLEMENT; MACROPHAGES; NEUROGLIA; OLIGODENDROGLIA; PHAGOCYTOSIS; RATS; SUPPORT, NON-U.S. GOV'T; TUMOR NECROSIS FACTOR;

EID: 0027082393     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/115.6.1611     Document Type: Article

References (49)

1. Adams DO, Hamilton TA (1984) The cell biology of macrophage activation. Annual Review of Immunology, 2, 283-318
2. Akiyama H, Kawamata T, Dedhar S, McGeer PL (1991) Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue. Journal of Neuroimmunology, 32, 19-28
3. Ashwell K (1991) The distribution of microglia and cell death in the fetal rat forebrain. Developmental Brain Research, 58, 1 -12
4. Barnum SR, Jones JL, Benveniste EN (1991) Interleukin-1b(IL-1b) and tumor necrosis factor a (TNFa) mediated regulation of C3 by D54-MG astroglioma cells and primary rat astrocytes: synergism with gamma interferon (IFN-y). Complement and Inflammation, 8, 127
5. Bensa JC, Reboul A, Colomb MG (1983) Biosynthesis in vitro of complement subcomponents Clq, Cls and Cl inhibitor by resting and stimulated human monocytes. Biochemical Journal, 216, 385-392
6. Brosnan CF, Bornstein MB, Bloom BR (1981) The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis. Journal of Immunology, 126, 614-620
7. Bruck W, Friede RL (1991) The role of complement in myelin phagocytosis during PNS wallerian degeneration. Journal of the Neurological Sciences, 103, 182 -187
8. Compston A, Scolding NJ, Wren D, Noble M (1991) The pathogenesis of demyelinating disease: insights from cell biology. Trends in Neuroscience, 14, 175-182
9. Decker T, Lohmann-Matthes M-L, Gifford GE (1987) Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. Journal of Immunology, 138, 957-962
10. Ezekowitz RAB, Austyn J, Stahl PD, Gordon S (1981) Surface properties of baccillus Calmette- Guerin-activated mouse macrophages. Journal of Experimental Medicine, 154, 60-76
11. 2a. Journal of Experimental Medicine, 157, 807-812
12. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-y-treated microglial cells. European Journal of Immunology. 17, 1271-1278
13. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A (1989) On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. European Journal of Immunology, 19, 689 -694
14. Giulian D, Baker TJ (1986) Characterization of ameboid microglia isolated from developing mammalian brain. Journal of Neuroscience, 6, 2163-2178
15. Giulian D, Baker TJ, Shih L-CN, Lachman LB (1986) Interleukin 1 of the central nervous system is produced by ameboid microglia. Journal of Experimental Medicine, 164, 594-604
16. Gould SJ, Howard S (1991) An immunohistological study of macrophages in the human fetal brain. Neuropathology and Applied Neurobiology, 17, 383 -390
17. Griffin FM, Mullinax P (1990) High concentrations of bacterial lipopolysaccharide, but not microbial infection-induced inflammation, activate macrophage C3 receptors for phagocytosis. Journal of Immunology, 145, 697-701
18. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. Journal of Experimental Medicine, 170, 607 -612
19. Jordan FL, Thomas WE (1988) Brain macrophages: questions of origin and interrelationship. Brain Research, Amsterdam, 472, 165 -178
20. Kuroda Y, Shimamoto Y (1991) Human tumor necrosis factor-a augments experimental allergic encephalomyelitis in rats. Journal of Neuroimmunology, 34, 159-164
21. Levison SW, McCarthy KD (1991) Astroglia in culture. In: Culturing Nerve Cells. Edited by G. Banker and K. Goslin. Cambridge, MA: MIT Press, pp. 309-336
22. Link H, Baig S, Jiang Y-P, Olsson O, Hojeberg B, Kostulas V et al. (1989) B cells and antibodies in MS. Research in Immunology, 140, 219 -226
23. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. Journal of Cell Biology, 85, 890-902
24. Merrill JE, Zimmerman RP (1991) Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFO. Glia, 4, 327 -331
25. Olsson T, Baig S, Hojeberg B, Link H (1990) Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis. Annals of Neurology, 27, 132-136
26. Perry VH, Gordon S (1991) Macrophages and the nervous system. International Review of Cytology, 125, 203 -244
27. Perry VH, Hume DA, Gordon S (1985) Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience, 15, 313 -326
28. Prineas JW (1985) The neuropathology of multiple sclerosis. In: Handbook of Clinical Neurology, Volume 47. Edited by P. J. Vinken, G. W. Bruyn and H. L. Klawans. Amsterdam: Elsevier, pp. 213-257
29. Rio-Hortega P del (1932) Microglia. In: Cytology and Cellular Pathology of the Nervous System, Volume 2. Edited by W. Penfield. New York: Paul B. Hoeber, pp. 481-534
30. Robbins DS, Shirazi Y, Drysdale B-E, Lieberman A, Shin HS, Shin ML (1987) Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. Journal of Immunology, 139, 2593-2597
31. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ. (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. Journal of Experimental Medicine, 172, 1193- 1200
32. Rus HG, Kim L, Niculescu F, Shin ML (1991) Regulation of C3 expression in rat astrocytes by LPS, cytokines and virus. Complement and Inflammation, 8, 217
33. Savill J, Dransfield I, Hogg N, Haslett C (1990) Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature, London, 343, 170-173
34. Scolding NJ, Compston DAS (1991) Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology, 72, 127-132
35. Scolding NJ, Morgan BP, Houston A, Campbell AK, Linington C, Compston DAS (1989) Normal rat serum cytotoxicity against syngeneic oligodendrocytes: complement activation and attack in the absence of anti-myelin antibodies. Journal of the Neurological Sciences, 89, 289-300
36. Selmaj KW, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Annals of Neurology, 23, 339-346
37. Selmaj K, Raine CS, Cannella B, Brosnan CF (1991a) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. Journal of Clinical Investigation, 87, 949-954
38. Selmaj K, Raine CS, Cross AH (1991b) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Annals of Neurology, 30, 694 -700
39. Sharief MK, Hentges R (1991) Association between tumor necrosis factor-a and disease progression in patients with multiple sclerosis. New England Journal of Medicine, 325, 467-472
40. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH (1987) MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of la antigen expression by y-interferon. Journal of Neuroimmunology, 15, 263-278
41. Tenner AJ, Volkin DB (1986) Complement subcomponent Clq secreted by cultured human monocytes has subunit structure identical with that of serum Clq. Biochemical Journal, 233, 451-458
42. Watson JV (1980) Enzyme kinetic studies in cell populations using fluorogenic substrates and flow cytometric techniques. Cytometry, 1, 143 -151
43. 4+ T lymphocyte clone is mediated by interferon-y and tumour necrosis factor alone or synergistically. Clinical and Experimental Immunology, 82, 208-213
44. Wing MG, Zajicek J, Seilly DJ, Compston DAS, Lachmann PJ (1992) Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59. Immunology, 76, 140-145
45. Woodroofe MN, Hayes GM, Cuzner ML (1989) Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain. Immunology, 68, 421-426
46. Wren DR, Noble M (1989) Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proceedings of the National Academy of Sciences of the USA, 86, 9025-9029
47. Xiao B-G, Linington C, Link H (1991) Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. Journal of Neuroimmunology, 31, 91 -96
48. Youl BD, Turano G, Miller DH, Towell AD, MacManus DG, Moore SG et al. (1991) The pathophysiology of acute optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits. Brain, 114, 2437-2450
49. Zajicek J, Wing MG, Lachmann PJ, Compston DAS (1992) Mechanisms of oligodendrocyte interaction with normal human serum—defining the role of complement. Journal of the Neurological Sciences, 108, 65-72